WPI (Raloxifene hydrochloride 60 mg)
This pill with imprint "WPI" is White, Elliptical / Oval and has been identified as Raloxifene hydrochloride 60 mg. It is supplied by Actavis Pharma, Inc..
Raloxifene is used in the treatment of breast cancer, prevention; prevention of osteoporosis; osteoporosis and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. Not for use in pregnancy. Raloxifene 60 mg is not a controlled substance under the Controlled Substance Act (CSA).
Raloxifene hydrochloride
- Imprint:
- WPI
- Strength:
- 60 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Hormones/antineoplastics
Selective estrogen receptor modulators - Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Actavis Pharma, Inc.
- National Drug Code (NDC):
- 00591-2367
More about raloxifene
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 5 Reviews – Add your own review/rating
- Drug class: hormones/antineoplastics
Consumer resources
Other brands: Evista
Professional resources
- Raloxifene Hydrochloride (AHFS Monograph)
- Raloxifene Hydrochloride Tablets (FDA)
- Raloxifene (Wolters Kluwer)
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
